Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)
Jo Lambert, Siegfried Segaert, Pierre‐Dominique Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 9, pp. 1914-1923
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Anna Campanati, Andrea Marani, Emanuela Martina, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1511-1511
Open Access | Times Cited: 80
Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
Bing‐Xi Yan, Xueyan Chen, Li‐Ran Ye, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 52
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review
Renata Finelli, Kristian Leisegang, Federica Finocchi, et al.
American Journal of Reproductive Immunology (2021) Vol. 85, Iss. 5
Closed Access | Times Cited: 31
Use of biologic treatment in psoriasis patients with HIV: A systematic review
Siddhartha Sood, Ryan S.Q. Geng, Martin Heung, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 1, pp. 107-108
Closed Access | Times Cited: 4
Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2629-2633
Open Access | Times Cited: 17
Psoriasis and cancer: experience of using IL-17 inhibitor in a patient with severe psoriasis and a history of prostate cancer
E.V. Svechnikova Svechnikova, S. Е. Zhufina
Meditsinskiy sovet = Medical Council (2025), Iss. 2, pp. 50-58
Open Access
Use of Systemic Therapies for Treatment of Psoriasis in Patients with a History of Treated Solid Tumours: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim Papp, Barbara Melosky, Sandeep Sehdev, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 867-889
Open Access | Times Cited: 8
Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities
Laura Mateu Arrom, L. Puig
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 4, pp. 363-379
Closed Access | Times Cited: 3
The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review
Marie Vangilbergen, Aline Stockman, Axelle Van De Velde, et al.
JAAD International (2024) Vol. 17, pp. 71-79
Open Access | Times Cited: 3
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
Marco Galluzzo, Andrea Chiricozzi, Élisa Cinotti, et al.
Expert Opinion on Biological Therapy (2021) Vol. 22, Iss. 3, pp. 367-376
Open Access | Times Cited: 20
Therapeutic challenges of psoriasis in the HIV‑infected patient: A case report
Manuela Arbune, Anca-Adriana Arbune, Elena Niculeț, et al.
Experimental and Therapeutic Medicine (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 17
[Translated article] Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis
L. Puig, J. Notario, A. López‐Ferrer, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 7, pp. T702-T711
Open Access | Times Cited: 2
Belgian recommendations for managing psoriasis in a changing treatment landscape
Reinhart Speeckaert, Arjen Nikkels, Jo Lambert, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 2
Systematic review and critical appraisal of psoriasis clinical practice guidelines: a Global Guidelines in Dermatology Mapping Project ( GUIDEMAP )*
Hsi Yen, Chun‐Hsien Huang, I‐Hsin Huang, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 2, pp. 178-187
Open Access | Times Cited: 11
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
Kim Papp, Jennifer Beecker, Curtis Cooper, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 5, pp. 1073-1089
Open Access | Times Cited: 11
A gene regulatory network approach harmonizes genetic and epigenetic signals and reveals repurposable drug candidates for multiple sclerosis
Astrid M. Manuel, Yulin Dai, Peilin Jia, et al.
Human Molecular Genetics (2022) Vol. 32, Iss. 6, pp. 998-1009
Open Access | Times Cited: 11
Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
Aikaterini Tsentemeidou, Elena Sotiriou, Nikolaos Sideris, et al.
Dermatology Practical & Conceptual (2022), pp. e2022179-e2022179
Open Access | Times Cited: 8
Overview, Management of the Infections in Psoriatic Patients Treated with Systemic Therapies: A lesson from the immunopathogenesis of psoriasis
Anna Balato, Emanuele Scala, Kilian Eyerich, et al.
Dermatology Practical & Conceptual (2023), pp. e2023016-e2023016
Open Access | Times Cited: 4
PsoPlus: An Integrated Practice Unit for Psoriasis
Niels Hilhorst, Elfie Deprez, Erin Roman, et al.
Dermatology (2023) Vol. 239, Iss. 3, pp. 334-344
Open Access | Times Cited: 4
New onset inflammatory bowel disease after initiation of anti-IL-17a treatment: a case series
J Geldof, Marie Truyens, Beatrijs Strubbe, et al.
Acta Gastro Enterologica Belgica (2024) Vol. 87, Iss. 3, pp. 413-417
Closed Access | Times Cited: 1
Psoriasis Flare Following Paramyxovirus Infection
Vito Di Lernia, Cristina Bertoli
Psoriasis Targets and Therapy (2024) Vol. Volume 14, pp. 131-134
Open Access | Times Cited: 1
Successful outcome of psoriasis in a laryngeal cancer patient treated with ixekizumab, a possible beneficial treatment for both pathologies
Saray Porcar Saura, Lucía Martínez Casimiro, Alejandro García‐Vázquez, et al.
Dermatology Online Journal (2021) Vol. 27, Iss. 6
Open Access | Times Cited: 8
Liver disease among patients with psoriasis: the Malaysian Psoriasis Registry
Yee Ting Lim, Suganthy Robinson, Min Moon Tang
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 5, pp. 476-483
Closed Access | Times Cited: 1
Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en psoriasis
L. Salgado-Boquete, S. Arias-Santiago, I. Belinchón, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 10, pp. 865-883
Open Access | Times Cited: 1
[Translated article] Selection of Quality Indicators for the Certification of Psoriasis Units: The CUDERMA Project Delphi Consensus Study
L. Salgado-Boquete, S. Arias-Santiago, I. Belinchón, et al.
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 10, pp. T865-T883
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top